1.5 g/d ALA | 9.5 g/d ALA | P value | |||||
---|---|---|---|---|---|---|---|
Male | Female | Male | Female | Sex | Diet | Sex*diet | |
(n = 11) | (n = 10) | (n = 13) | (n = 10) | ||||
Age (y) | 52.9 ± 13.7 | 53.0 ± 11.2 | 50.5 ± 12.7 | 53.5 ± 12.0 | 0.68 | 0.80 | 0.70 |
Weight (kg) | 82.3 ± 8.8 | 62.9 ± 7.4* | 84.7 ± 14.3 | 69.9 ± 9.2* | <0.001 | 0.15 | 0.47 |
BMI (kg/m2) | 26.4 ± 2.7 | 24.2 ± 3.1 | 27.3 ± 3.9 | 25.6 ± 2.6 | 0.053 | 0.24 | 0.82 |
ALA dose per kg body weight (mg/d) | 18.4 ± 1.9 | 24.2 ± 2.6* | 115.5 ± 22.0† | 137.8 ± 16.8†* | 0.003 | <0.001 | 0.067 |
Baseline plasma phospholipid n-3 fatty acid status (% total fatty acids) | |||||||
ALA (18:3n-3) | 0.3 ± 0.1 | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.63 | 0.20 | 0.75 |
EPA (20:5n-3) | 0.9 ± 0.8 | 1.1 ± 0.9 | 0.8 ± 0.6 | 0.8 ± 0.5 | 0.55 | 0.48 | 0.73 |
DPA (22:5n-3) | 2.1 ± 1.5 | 1.6 ± 0.7 | 1.9 ± 0.7 | 1.8 ± 0.9 | 0.34 | 0.98 | 0.63 |
DHA (22:6n-3) | 4.4 ± 1.3 | 4.2 ± 1.3 | 3.5 ± 1.0 | 3.2 ± 0.9 | 0.63 | 0.008 | 0.86 |